These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16285987)

  • 1. The natural history of NAFLD: impressively unimpressive.
    Ioannou GN
    Gastroenterology; 2005 Nov; 129(5):1805. PubMed ID: 16285987
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
    Ekstedt M; Franzén LE; Mathiesen UL; Thorelius L; Holmqvist M; Bodemar G; Kechagias S
    Hepatology; 2006 Oct; 44(4):865-73. PubMed ID: 17006923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
    Ong JP; Pitts A; Younossi ZM
    J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?
    Roberts EA
    J Hepatol; 2007 Jun; 46(6):1133-42. PubMed ID: 17445934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
    Rubinstein E; Lavine JE; Schwimmer JB
    Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease in children: a single center experience.
    A-Kader HH; Henderson J; Vanhoesen K; Ghishan F; Bhattacharyya A
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):799-802. PubMed ID: 18486560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of NAFLD: remarkably benign in the absence of cirrhosis.
    Day CP
    Gastroenterology; 2005 Jul; 129(1):375-8. PubMed ID: 16012969
    [No Abstract]   [Full Text] [Related]  

  • 9. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
    Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of histological features in non-alcoholic fatty liver disease.
    Vasdev N; Kakati AG; Saigal S; Nayak NC
    Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.
    Gan SK; Adams LA; Watts GF
    Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and natural history of metabolic steatosis: histology and cellular aspects.
    Paradis V; Bedossa P
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):638-42. PubMed ID: 19195624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and natural history of NAFLD and NASH.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF; Diehl AM
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on non-alcoholic fatty liver disease in children.
    Papandreou D; Rousso I; Mavromichalis I
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.